HomeAI · summaries
Storia in 4 fonti
Guardant Health Hit With Royalties Over Duplex Sequencing Tech - Guardant Health (NASDAQ:GH)
Guardant Health must pay TwinStrand Biosciences and the University of Washington over $245 million after a court finalized a patent dispute.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
TwinStrand Biosciences Announces Final Judgment in Patent Infringement Suit Against Guardant Health, Awarding TwinStrand and the University…
TwinStrand Biosciences Announces Final Judgment in Patent Infringement Suit Against Guardant Health, Awarding TwinStrand and the University of Washington More Than $245.2 Million…
- ·
investors.com
Guardant Bleeds After Losing A Costly Patent Dispute
Guardant Health stock tumbled Monday after losing a patent battle against privately held TwinStrand Biosciences.
